You are here

New cholesterol methods needed in wake of failed drugs: researchers


NEW ways of controlling cholesterol, including possibly directly injecting "good" HDL cholesterol into patients, need to be studied following the failure of promising treatments from Eli Lilly, Pfizer Inc and Roche Holding AG, according to top heart researchers.

Lilly in

Market voices on:

Powered by GET.comGetCom